Table 2.
Antioxidants effects of SMC in control and experimental groups of rats
| Groups | MDA (µM/L) | CAT (katal/ml) | GPx (mg/g Hb) | GSH (mg/g Hb) |
|---|---|---|---|---|
| Control | 2.56±0.28 | 42.70±18.43 | 42.89±8.19 | 6.57±1.45 |
| Control+SMC | 2.68±0.46 | 41.04±10.78 | 51.83±13.11 | 9.64±0.47 |
| HFD | 4.28±0.88a,b,c | 30.99±4.64c | 29.36±5.76c | 3.42±0.62a,b,c |
| HFD+SMC | 2.91±0.17 | 47.54±16.09 | 43.56±10.12 | 6.75±1.20 |
| HFD+metformin | 2.59±0.30 | 56.92±16.09 | 51.69±7.03b | 7.38±1.24 |
a: Significantly different with control; b: Significantly different with SMC group; c: Significantly different with HFD+metformin at 5% level of significant (P<0.05)